| Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children A Drilon, TW Laetsch, S Kummar, SG DuBois, UN Lassen, GD Demetri, ... New England Journal of Medicine 378 (8), 731-739, 2018 | 2557 | 2018 |
| Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer MR Posner, DM Hershock, CR Blajman, E Mickiewicz, E Winquist, ... New England Journal of Medicine 357 (17), 1705-1715, 2007 | 2082 | 2007 |
| Liquid biopsy for advanced non-small cell lung cancer (NSCLC): a statement paper from the IASLC C Rolfo, PC Mack, GV Scagliotti, P Baas, F Barlesi, TG Bivona, RS Herbst, ... Journal of thoracic oncology 13 (9), 1248-1268, 2018 | 637 | 2018 |
| Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer EEW Cohen, TG Karrison, M Kocherginsky, J Mueller, R Egan, CH Huang, ... Journal of clinical oncology 32 (25), 2735-2743, 2014 | 559 | 2014 |
| A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors LE Raez, K Papadopoulos, AD Ricart, EG Chiorean, RS DiPaola, ... Cancer chemotherapy and pharmacology 71, 523-530, 2013 | 502 | 2013 |
| EGFR targeting of solid tumors CM Rocha-Lima, HP Soares, LE Raez, R Singal Cancer control 14 (3), 295-304, 2007 | 391 | 2007 |
| Liquid biopsy for advanced NSCLC: a consensus statement from the international association for the study of lung cancer C Rolfo, P Mack, GV Scagliotti, C Aggarwal, ME Arcila, F Barlesi, T Bivona, ... Journal of Thoracic Oncology 16 (10), 1647-1662, 2021 | 381 | 2021 |
| Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial RG Martins, U Parvathaneni, JE Bauman, AK Sharma, LE Raez, ... Journal of clinical oncology 31 (11), 1415-1421, 2013 | 243 | 2013 |
| Total mutation burden (TMB) in lung cancer (LC) and relationship with response to PD-1/PD-L1 targeted therapies. DR Spigel, AB Schrock, D Fabrizio, GM Frampton, J Sun, J He, K Gowen, ... Journal of Clinical Oncology 34 (15_suppl), 9017-9017, 2016 | 205 | 2016 |
| Exosome-Based Detection of EGFR T790M in Plasma from Non–Small Cell Lung Cancer Patients E Castellanos-Rizaldos, DG Grimm, V Tadigotla, J Hurley, J Healy, ... Clinical cancer research 24 (12), 2944-2950, 2018 | 196 | 2018 |
| Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non–small-cell lung cancer MP Fanucchi, FV Fossella, R Belt, R Natale, P Fidias, DP Carbone, ... Journal of Clinical Oncology 24 (31), 5025-5033, 2006 | 188 | 2006 |
| DeCIDE: A phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F)(TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell … EEW Cohen, T Karrison, M Kocherginsky, CH Huang, M Agulnik, BB Mittal, ... Journal of Clinical Oncology 30 (15_suppl), 5500-5500, 2012 | 186 | 2012 |
| Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation MR Posner, CM Norris, LJ Wirth, DM Shin, KJ Cullen, EW Winquist, ... Annals of oncology 20 (5), 921-927, 2009 | 179 | 2009 |
| Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy? JA Pinto, CS Vallejos, LE Raez, LA Mas, R Ruiz, JS Torres-Roman, ... ESMO open 3 (3), e000344, 2018 | 145 | 2018 |
| Entrectinib: a potent new TRK, ROS1, and ALK inhibitor C Rolfo, R Ruiz, E Giovannetti, I Gil-Bazo, A Russo, F Passiglia, ... Expert opinion on investigational drugs 24 (11), 1493-1500, 2015 | 143 | 2015 |
| Allogeneic vaccination with a B7. 1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non–small-cell lung cancer LE Raez, PA Cassileth, JJ Schlesselman, K Sridhar, S Padmanabhan, ... Journal of Clinical Oncology 22 (14), 2800-2807, 2004 | 142 | 2004 |
| Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer A Argiris, MV Karamouzis, WE Gooding, BF Branstetter, S Zhong, ... Journal of Clinical Oncology 29 (9), 1140-1145, 2011 | 131 | 2011 |
| Viroglio Rdel C MR Posner, DM Hershock, CR Blajman, E Mickiewicz, E Winquist, ... Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM …, 2007 | 124 | 2007 |
| Advantage of EUS Trucut biopsy combined with fine-needle aspiration without immediate on-site cytopathologic examination I Storch, M Jorda, R Thurer, L Raez, C Rocha-Lima, S Vernon, A Ribeiro Gastrointestinal endoscopy 64 (4), 505-511, 2006 | 124 | 2006 |
| Active immunotherapy for non-small-cell lung cancer: moving toward a reality CA Perez, ES Santos, LE Raez Expert Review of Anticancer Therapy 11 (10), 1599-1605, 2011 | 109 | 2011 |
Christian RolfoProfessor in Oncology, Head of Phase I -Early Clinical Trials Unit, Oncology, Antwerp University在 uza.be 的电子邮件经过验证
